<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02563873</url>
  </required_header>
  <id_info>
    <org_study_id>12/YH/0097</org_study_id>
    <nct_id>NCT02563873</nct_id>
  </id_info>
  <brief_title>Bowditch Revisited: Defining the Optimum Heart Rate Range in Chronic Heart Failure</brief_title>
  <official_title>Bowditch Revisited: Defining the Optimum Heart Rate Range in Chronic Heart Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Leeds</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute for Health Research, United Kingdom</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Leeds</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators are examining the relationship between heart rate and heart contraction in
      patients with heart failure and pacemakers, aiming to improve quality of life.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Heart rate lowering is a cornerstone of the management of chronic heart failure (CHF) and the
      degree of lowering is closely related to improvements in longevity, hospitalisation rate and
      heart function. The investigators have shown that increasing heart rates using pacemakers
      does not increase exercise capacity in CHF patients. This might be because the optimal heart
      rate range for contraction is narrower for patients with CHF. At higher heart rates, heart
      contraction might be less strong. The investigators now want to examine the relationship
      between heart rate and heart contraction in patients with heart failure and pacemakers.
      Tailored pacemaker heart rate setting's, individually optimised for heart contractility as
      assessed by cardiac ultrasound, will be investigated to examine the effects on exercise
      tolerance .
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2015</start_date>
  <completion_date type="Anticipated">July 2018</completion_date>
  <primary_completion_date type="Anticipated">July 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Exercise Time</measure>
    <time_frame>Assessed following the second treadmill test, 1 week later</time_frame>
    <description>Exercise duration in seconds</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Peak Oxygen Consumption (pVO2)</measure>
    <time_frame>Assessed following the second treadmill test, 1 week later</time_frame>
    <description>Peak Oxygen Consumption (pVO2) measured by metabolic gas exchange</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">110</enrollment>
  <condition>Chronic Heart Failure</condition>
  <arm_group>
    <arm_group_label>Standard pacemaker settings</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard pacemaker settings will be programmed and the patient will complete a symptom limited exercise tolerance test with metabolic gas exchange</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tailored pacemaker settings</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The pacemaker settings will be altered to match optimal heart rate range with respect to cardiac contractility, as determined by echocardiography. This will be programmed and the patient will complete a symptom limited exercise tolerance test with metabolic gas exchange.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Tailored pacemaker settings</intervention_name>
    <description>Tailored pacemaker settings, optimised for cardiac contractility: Pacemaker settings, optimised for cardiac contractility as determined by echocardiography, will be programmed</description>
    <arm_group_label>Tailored pacemaker settings</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  stable CHF

          -  Cardiac Resynchronisation Therapy (CRT) device for &gt;3 months,

          -  able to walk on treadmill

        Exclusion Criteria:

          -  unable to walk on treadmill,

          -  unstable angina pectoris

          -  uncontrolled heart rate

          -  prescribed calcium channel blocker

          -  significant aortic stenosis

          -  significant airways disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John Gierula, BSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Leeds</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>John Gierula, BSc</last_name>
    <phone>00441333923131</phone>
    <email>J.Gierula@leeds.ac.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Klaus K Witte, MD</last_name>
    <email>k.k.witte@leeds.ac.uk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Leeds Institute of Cardiovascular and Metabolic Medicine</name>
      <address>
        <city>Leeds</city>
        <state>West Yorkshire</state>
        <zip>LS2 9JT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Gierula, BSc</last_name>
      <phone>01133923131</phone>
      <email>j.gierula@leeds.ac.uk</email>
    </contact>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <reference>
    <citation>Al-Najjar Y, Witte KK, Clark AL. Chronotropic incompetence and survival in chronic heart failure. Int J Cardiol. 2012 May 17;157(1):48-52. doi: 10.1016/j.ijcard.2010.11.018. Epub 2010 Dec 23.</citation>
    <PMID>21185094</PMID>
  </reference>
  <reference>
    <citation>Shelton RJ, Ingle L, Rigby AS, Witte KK, Cleland JG, Clark AL. Cardiac output does not limit submaximal exercise capacity in patients with chronic heart failure. Eur J Heart Fail. 2010 Sep;12(9):983-9. doi: 10.1093/eurjhf/hfq086. Epub 2010 Jun 4.</citation>
    <PMID>20525704</PMID>
  </reference>
  <reference>
    <citation>Witte KK, Clark AL. Chronotropic incompetence does not contribute to submaximal exercise limitation in patients with chronic heart failure. Int J Cardiol. 2009 May 29;134(3):342-4. doi: 10.1016/j.ijcard.2008.02.014. Epub 2008 Jun 20.</citation>
    <PMID>18571253</PMID>
  </reference>
  <reference>
    <citation>Thackray SD, Ghosh JM, Wright GA, Witte KK, Nikitin NP, Kaye GC, Clark AL, Tweddel A, Cleland JG. The effect of altering heart rate on ventricular function in patients with heart failure treated with beta-blockers. Am Heart J. 2006 Oct;152(4):713.e9-13.</citation>
    <PMID>16996845</PMID>
  </reference>
  <reference>
    <citation>Witte KK, Clark AL. Resting left ventricular function, however measured, is poorly related to exercise capacity in chronic heart failure. Am J Cardiol. 2006 Sep 1;98(5):709-10. Epub 2006 Jul 5.</citation>
    <PMID>16923470</PMID>
  </reference>
  <reference>
    <citation>Witte KK, Clark AL. Chronotropic incompetence in heart failure. J Am Coll Cardiol. 2006 Aug 1;48(3):595; author reply 595-6. Epub 2006 Jul 12.</citation>
    <PMID>16875998</PMID>
  </reference>
  <reference>
    <citation>Witte KK, Cleland JG, Clark AL. Chronic heart failure, chronotropic incompetence, and the effects of beta blockade. Heart. 2006 Apr;92(4):481-6. Epub 2005 Sep 13.</citation>
    <PMID>16159968</PMID>
  </reference>
  <reference>
    <citation>Thackray SD, Witte KK, Nikitin NP, Clark AL, Kaye GC, Cleland JG. The prevalence of heart failure and asymptomatic left ventricular systolic dysfunction in a typical regional pacemaker population. Eur Heart J. 2003 Jun;24(12):1143-52.</citation>
    <PMID>12804929</PMID>
  </reference>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 22, 2015</study_first_submitted>
  <study_first_submitted_qc>September 28, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 30, 2015</study_first_posted>
  <last_update_submitted>May 10, 2016</last_update_submitted>
  <last_update_submitted_qc>May 10, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 11, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Leeds</investigator_affiliation>
    <investigator_full_name>John Gierula</investigator_full_name>
    <investigator_title>NIHR Fellow and Cardiac Physiologist</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>May 1, 2018</submitted>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

